Cargando…
Conflicting Interpretation of Genetic Variants and Cancer Risk by Commercial Laboratories as Assessed by the Prospective Registry of Multiplex Testing
PURPOSE: Massively parallel sequencing allows simultaneous testing of multiple genes associated with cancer susceptibility. Guidelines are available for variant classification; however, interpretation of these guidelines by laboratories and providers may differ and lead to conflicting reporting and,...
Autores principales: | Balmaña, Judith, Digiovanni, Laura, Gaddam, Pragna, Walsh, Michael F., Joseph, Vijai, Stadler, Zsofia K., Nathanson, Katherine L., Garber, Judy E., Couch, Fergus J., Offit, Kenneth, Robson, Mark E., Domchek, Susan M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Clinical Oncology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5562435/ https://www.ncbi.nlm.nih.gov/pubmed/27621404 http://dx.doi.org/10.1200/JCO.2016.68.4316 |
Ejemplares similares
-
NBN Pathogenic Germline Variants are Associated with Pan-Cancer Susceptibility and In Vitro DNA Damage Response Defects
por: Belhadj, Sami, et al.
Publicado: (2023) -
Towards Automation of Germline Variant Curation in Clinical Cancer Genetics
por: Ravichandran, Vignesh, et al.
Publicado: (2019) -
Author Correction: The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk
por: Slavin, Thomas P., et al.
Publicado: (2017) -
The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk
por: Slavin, Thomas P., et al.
Publicado: (2017) -
Multiplex communities and the emergence of international conflict
por: Pomeroy, Caleb, et al.
Publicado: (2019)